schülke’s launch of sensiva® SC 50 (ethylhexylglycerin) gave the personal care industry its first truly multifunctional additive; combining antimicrobial boosting with additional functions:
- In-vitro tests show a selective activity on odor causing Gram-positive bacteria. sensiva® SC 50 can be used as a deodorant active. It has minimal effect on the microbiome as compared to triclosan, which indiscriminately eliminated all microorganisms.
- Studies combining sensiva® SC 50 with alcohols and glycols prove a true synergy, boosting preservative and antimicrobial efficacy in finished formulations.
- As a medium-spreading emollient, ethylhexylglycerin is able to improve the skin-feel of personal care formulations. sensiva® SC 50 in combination with glycerin can produce a formulation that feels less tacky and greasy, with improved penetration and lower soaping.
The recent pandemic has refocused the world’s attention on antimicrobials. With increasing use of hand sanitizers, the prevalence of dry, irritated hands is a real issue. sensiva® SC 50 not only boosts the antimicrobial efficacy, it also helps to improve the moisturization of the skin after use.
Prevention of contamination, both on skin and in product, has never been more important to manufacturers and consumers. This is familiar territory to schülke, which was founded in 1889 with the singular focus to protect people and products worldwide against infection and microbial contamination.
As one of the leading manufacturers in the field of infection prevention and hygiene for more than 130 years Schülke & Mayr GmbH is developing, producing and distributing antiseptics for wound care, disinfectants, medical and cosmetic skin care products and preservatives. Its core business areas include healthcare, industrial hygiene, personal care and over the counter (OTC). Innovative products, technologies and services all contribute to fulfill schülke’s mission to protect lives worldwide and thereby actively contributes to patient safety. Today schülke is represented by 20 subsidiaries and sells its products in more than 100 countries. The company is headquartered in Germany, employs more than 1,300 people worldwide and operates production sites in Germany (schülke), France (Bioxal) and Brazil (Vic Pharma). www.schuelke.com